Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion

AI Briefing

• – Eli Lilly in talks to acquire Kelonia Therapeutics for $2 billion
• – Pharmaceutical giant to expand its portfolio with new oncology and cardiovascular treatments
• – Deal could be finalized in the coming months